Steven J. Mento
2017
In 2017, Steven J. Mento earned a total compensation of $1.3M as President and Chief Executive Officer at Conatus Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $208,573 |
|---|---|
| Option Awards | $556,346 |
| Salary | $521,433 |
| Other | $16,645 |
| Total | $1,302,997 |
Mento received $556.3K in option awards, accounting for 43% of the total pay in 2017.
Mento also received $208.6K in non-equity incentive plan, $521.4K in salary and $16.6K in other compensation.
Rankings
In 2017, Steven J. Mento's compensation ranked 7,715th out of 14,666 executives tracked by ExecPay. In other words, Mento earned more than 47.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,715 out of 14,666 | 47th |
Division Manufacturing | 2,887 out of 5,772 | 50th |
Major group Chemicals And Allied Products | 939 out of 2,075 | 55th |
Industry group Drugs | 726 out of 1,731 | 58th |
Industry Pharmaceutical Preparations | 565 out of 1,333 | 58th |
Source: SEC filing on April 27, 2018.
Mento's colleagues
We found two more compensation records of executives who worked with Steven J. Mento at Conatus Pharmaceuticals in 2017.